Sign in
Not yet recruitingNo phase

Testing a new memory and thinking test for mild cognitive impairment and dementia

Checks how well the ASCA test detects mild cognitive impairment and dementia in older adults.

Key facts

Who runs it
Ain Shams University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Validating the Ain Shams Cognitive Assessment Tool
Status
Not yet recruiting
People taking part
100 people, planned
Started
1 Feb 2025
Planned end
1 Jun 2025
Type of study
Observational, 3 groups
Treatments tested
  • Ain Shams University Cognitive Assessment (ASCA) tool
Record updated
23 January 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 60 and above who are native Arabic speakers. It includes people with dementia, people with mild cognitive impairment (memory and thinking problems), and healthy people. It tests a memory and thinking test called ASCA.

Age
60 years and above
Sex
All
Disease stage
Dementia or mild cognitive impairment diagnosed by DSM-5 criteria, or healthy controls. Severe dementia is not allowed.

Main reasons for not taking part

  • Severe dementia
  • Delirium (sudden confusion)
  • Major mental disorders
  • Aphasia (trouble with speech or language)
  • Severe sight or hearing problems that get in the way of the test

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • -

Who cannot take part

  • severe dementia, delirium, major mental disorders, aphasia, and those with severe visual or hearing impairment that interfere with the assessment

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The diagnosis of cognitive impairment, including dementia and mild cognitive impairment (MCI), is crucial for timely intervention and management. Various screening tools are available for assessing cognitive function, among which the Mini-Mental State Examination (MMSE), the Addenbrooke's Cognitive Examination (ACE), and the Montreal Cognitive Assessment (MoCA) are widely used. However, the recently developed Ain Shams University Cognitive Assessment (ASCA) has shown promise in detecting early cognitive decline. This study aims to assess the performance of ASCA in diagnosing cognitive impairment against DSM5 criteria.

The 3 groups in the trial

  • Dementia

    participants \>60 years with Dementia diagnosed by DSM-5 criteria

    Treatment: Ain Shams University Cognitive Assessment (ASCA) tool

  • Mild cognitive impairment

    participants \>60 years with Mild cognitive impairment (MCI) diagnosed by DSM-5 criteria

    Treatment: Ain Shams University Cognitive Assessment (ASCA) tool

  • control

    euthymic healthy community dwelling adult participants of various socioeconomic and educational status.

    Treatment: Ain Shams University Cognitive Assessment (ASCA) tool

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Validating the Ain Shams Cognitive Assessment (ASCA) for Diagnosing Mild Cognitive Impairment and Dementia
Plain-language title
Testing a new memory and thinking test for mild cognitive impairment and dementiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
23 January 2025